References
- Kim JB. Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol 2005;15:365–77
- Siolas D, Hannon GJ. Patient-derived tumor xenografts: transforming clinical samples into mouse models. Cancer Res 2013;73:5315–19
- Abbott A. Cell culture: biology's new dimension. Nature 2003;424:870–2
- Schmeichel KL, Bissell MJ. Modeling tissue-specific signaling and organ function in three dimensions. J Cell Sci 2003;116:2377–88
- Breslin S, O’Driscoll L. Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today 2013;18:240–9
- Tung YC, Hsiao AY, Allen SG, et al. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst 2011;136:473–8
- Hranjec M, Kralj M, Piantanida I, et al. Novel cyano- and amidino-substituted derivatives of styryl-2-benzimidazoles and benzimidazo[1,2-a]quinolines. Synthesis, photochemical synthesis, DNA binding and antitumor evaluation, Part 3. J Med Chem 2007;50:5696–711
- Hranjec M, Piantanida I, Kralj M, et al. Novel amidino-substituted thienyl- and furyl-vinyl-benzimidazole derivatives and their photochemical conversion into corresponding diaza-cyclopenta[c]fluorenes. Synthesis, interactions with DNA and RNA and antitumor evaluation, Part 4. J Med Chem 2008;51:4899–910
- Hranjec M, Lučić B, Ratkaj I, Karminski-Zamola G. Novel imidazo[4,5-b]pyridine and triaza-benzo[c]fluorene derivatives: synthesis, antiproliferative activity and DNA binding studies. Eur J Med Chem 2011;46:2748
- Sedić M, Poznić M, Gehrig P, et al. Differential anti-proliferative mechanisms of novel derivative of benzimidazo[1,2-a] quinoline in colon cancer cells depending on their p53 status. Mol Cancer Ther 2008;7:2121–32
- Weaver VM, Lelièvre S, Lakins JN, et al. β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2002;2:205–16
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63
- Réjiba S, Bigand CH, Parmentier C, Hajri A. Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies. Neoplasia 2009;11:637–50
- Coyne CP, Jones T, Bear R. Anti-neoplastic cytotoxicity of gemcitabine-(C4-amide)-[anti-HER2/neu] in combination with Griseofulvin against chemotherapeutic-resistant mammary adenocarcinoma (SKBr-3). Med Chem 2013;3:210–23
- Awasthi N, Zhang C, Schwarz AM, et al. Comparative benefits of Nab-paclitaxel over gemcitabine or polysorbate-based docetaxel in experimental pancreatic cancer. Carciongenesis 2013;34:2361–9